IBDEI11J ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16916,0)
 ;;=R50.82^^61^777^27
 ;;^UTILITY(U,$J,358.3,16916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16916,1,3,0)
 ;;=3^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,16916,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,16916,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,16917,0)
 ;;=R50.83^^61^777^29
 ;;^UTILITY(U,$J,358.3,16917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16917,1,3,0)
 ;;=3^Fever,Postvaccination
 ;;^UTILITY(U,$J,358.3,16917,1,4,0)
 ;;=4^R50.83
 ;;^UTILITY(U,$J,358.3,16917,2)
 ;;=^5019510
 ;;^UTILITY(U,$J,358.3,16918,0)
 ;;=R50.84^^61^777^28
 ;;^UTILITY(U,$J,358.3,16918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16918,1,3,0)
 ;;=3^Fever,Posttransfusion
 ;;^UTILITY(U,$J,358.3,16918,1,4,0)
 ;;=4^R50.84
 ;;^UTILITY(U,$J,358.3,16918,2)
 ;;=^5019511
 ;;^UTILITY(U,$J,358.3,16919,0)
 ;;=B02.23^^61^777^74
 ;;^UTILITY(U,$J,358.3,16919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16919,1,3,0)
 ;;=3^Postherpetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,16919,1,4,0)
 ;;=4^B02.23
 ;;^UTILITY(U,$J,358.3,16919,2)
 ;;=^266550
 ;;^UTILITY(U,$J,358.3,16920,0)
 ;;=B02.22^^61^777^75
 ;;^UTILITY(U,$J,358.3,16920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16920,1,3,0)
 ;;=3^Postherpetic Trigeminal Neuralgia
 ;;^UTILITY(U,$J,358.3,16920,1,4,0)
 ;;=4^B02.22
 ;;^UTILITY(U,$J,358.3,16920,2)
 ;;=^266546
 ;;^UTILITY(U,$J,358.3,16921,0)
 ;;=J03.91^^61^777^87
 ;;^UTILITY(U,$J,358.3,16921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16921,1,3,0)
 ;;=3^Tonsillitis,Acute Recurrent,Unspec
 ;;^UTILITY(U,$J,358.3,16921,1,4,0)
 ;;=4^J03.91
 ;;^UTILITY(U,$J,358.3,16921,2)
 ;;=^5008136
 ;;^UTILITY(U,$J,358.3,16922,0)
 ;;=U07.1^^61^777^16
 ;;^UTILITY(U,$J,358.3,16922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16922,1,3,0)
 ;;=3^COVID-19
 ;;^UTILITY(U,$J,358.3,16922,1,4,0)
 ;;=4^U07.1
 ;;^UTILITY(U,$J,358.3,16922,2)
 ;;=^5159070
 ;;^UTILITY(U,$J,358.3,16923,0)
 ;;=A84.81^^61^777^76
 ;;^UTILITY(U,$J,358.3,16923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16923,1,3,0)
 ;;=3^Powassan Virus Disease
 ;;^UTILITY(U,$J,358.3,16923,1,4,0)
 ;;=4^A84.81
 ;;^UTILITY(U,$J,358.3,16923,2)
 ;;=^5159071
 ;;^UTILITY(U,$J,358.3,16924,0)
 ;;=A84.89^^61^777^85
 ;;^UTILITY(U,$J,358.3,16924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16924,1,3,0)
 ;;=3^Tick-Borne Viral Encephalitis,Other
 ;;^UTILITY(U,$J,358.3,16924,1,4,0)
 ;;=4^A84.89
 ;;^UTILITY(U,$J,358.3,16924,2)
 ;;=^5159072
 ;;^UTILITY(U,$J,358.3,16925,0)
 ;;=A84.9^^61^777^86
 ;;^UTILITY(U,$J,358.3,16925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16925,1,3,0)
 ;;=3^Tick-Borne Viral Encephalitis,Unspec
 ;;^UTILITY(U,$J,358.3,16925,1,4,0)
 ;;=4^A84.9
 ;;^UTILITY(U,$J,358.3,16925,2)
 ;;=^5000426
 ;;^UTILITY(U,$J,358.3,16926,0)
 ;;=Z11.52^^61^777^17
 ;;^UTILITY(U,$J,358.3,16926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16926,1,3,0)
 ;;=3^COVID-19 Screening
 ;;^UTILITY(U,$J,358.3,16926,1,4,0)
 ;;=4^Z11.52
 ;;^UTILITY(U,$J,358.3,16926,2)
 ;;=^5160186
 ;;^UTILITY(U,$J,358.3,16927,0)
 ;;=Z20.822^^61^777^21
 ;;^UTILITY(U,$J,358.3,16927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16927,1,3,0)
 ;;=3^Contact with & Suspected Exposure to COVID-19
 ;;^UTILITY(U,$J,358.3,16927,1,4,0)
 ;;=4^Z20.822
 ;;^UTILITY(U,$J,358.3,16927,2)
 ;;=^5160187
 ;;^UTILITY(U,$J,358.3,16928,0)
 ;;=Z86.16^^61^777^68
 ;;^UTILITY(U,$J,358.3,16928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16928,1,3,0)
 ;;=3^Personal Hx of COVID-19
